Browsing "1. Journal Papers" by Identifier : 0008-543X

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 15 to 31 of 31

This table browses all dspace content
Issue DateTitleJournal Title
1997High Level of Urokinase-Type Plasminogen Activator Is a New Prognostic Marker in Patients with Gastric CarcinomaCANCER
2007Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung CANCER
2012Identification of novel immunogenic human leukocyte antigen-A 2402-binding epitopes of human papillomavirus type 16 E7 for immunotherapy against human cervical cancer.CANCER
2013Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteriaCANCER
2021Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 studyCANCER
2006Oncogenic T-antigen of JC virus is present frequently in human gastric cancers CANCER
2014Patient-Reported Outcomes From EMILIA, a Randomized Phase 3 Study of Trastuzumab Emtansine (T-DM1) Versus Capecitabine and Lapatinib in Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Breast CancerCANCER
2020Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinomaCANCER
2015Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinomaCANCER
2012Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma. CANCER
2007Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer CANCER
2008Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis. CANCER
2009Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. CANCER
2007Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma CANCER
2016Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumCANCER
2018Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea.CANCER
2001The significance of granzyme B expression in patients with angiocentric lymphoma of the head and neckCANCER
1

Browse

Links